Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/27399| Title: | Pulmonary embolus in patients with COVID-19: an Australian perspective. | Austin Authors: | Robinson, Danielle H ;Wimaleswaran, Hari ;McDonald, Christine F ;Howard, Mark E ;Willcox, Abbey | Affiliation: | Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia Respiratory and Sleep Medicine Institute for Breathing and Sleep Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia Clinical Haematology |
Issue Date: | Aug-2021 | Publication information: | Internal Medicine Journal 2021; 51(8): 1324-1327 | Abstract: | Pulmonary embolus (PE) is a known complication of coronavirus disease 2019 (COVID-19). The diagnosis of PE in our hospitalised patients with COVID-19 correlated with more severe disease and occurred despite the use of routine thromboprophylaxis. Higher D-dimers were seen on admission in patients who developed PE and rose at PE diagnosis, suggesting a role for D-dimer in risk stratification. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/27399 | DOI: | 10.1111/imj.15405 | ORCID: | 0000-0003-0384-704X | Journal: | Internal Medicine Journal | PubMed URL: | 34423548 | Type: | Journal Article | Subjects: | COVID-19 D-dimer pulmonary embolism thrombosis |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.